Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors within the central nervous procedure, conolidine modulates alternate molecular targets. A Science Improvements review observed that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid pe... https://tonyw184zod0.wikinewspaper.com/user